Glimepiride Tablets IP 4 MG – GLIMRIL 4

Glimepiride Tablets IP 4 mg – Drug with best in class effect and safety profile.

GLIMRIL 4 – Glimepiride 4 mg is a sulfonylurea anti-diabetic agent that works with a dual mechanism-
To stimulate the insulin secreting beta cells to enhance the insulin production to manage elevated blood glucose levels.
To enhance sensitivity of peripheral tissues to insulin that promotes glucose uptake.

Recommended by specialists:
✅Diabetologist: To treat Type 2 diabetes and for Inadequate Glycemic Control.
✅Cardiologist: To manage T2DM with cardiovascular disease
✅General Physician: For the management of spikes in blood glucose levels after meal (Postprandial hypoglycaemia).

Key benefits of Glimepiride Tablets IP 4 MG – GLIMRIL 4:
✅Prolonged effect for postprandial hypoglycaemia:  Glimepiride provides effect for a longer time, which is suitable for the patients experiencing spikes in blood sugar after meals (postprandial hypoglycaemia).
✅Better safety profile:  In comparison with other sulfonylurea derivatives like Glipizide & Glibenclamide, it has a better cardiovascular safety profile.
✅Reduces risk of hypoglycemia:  Glimepiride has a lower risk of hypoglycemia as compared to other sulfonylurea derivatives, Glibenclamide.

Indications
✅Type 2 Diabetes
✅Inadequate Glycemic Control
✅Postprandial hypoglycaemia
✅ T2DM with cardiovascular disease